Gotistobart is a next-generation anti-cytotoxic T-lymphocyte-associated protein 4 antibody candidate ... despite prior treatment with a programmed cell death protein 1 or programmed death ligand ...
A recent study from the University of Würzburg unveiled a key enzyme involved in producing selenoproteins, opening new strategies for treating certain types of cancer in children.
“These data support the hypothesis that CTLA-4 inhibition can mitigate the ... destruction and limited the efficacy of programmed cell death protein 1 (PD-1) blockade. Dual checkpoint blockade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback